NanoBiotechnology Group

19/08/2020

‪The Medical Research Future Fund (MRFF) was created in 2014 to help fund Australian medical research. It has been apparent that the awarding of these disbursements is flawed. Do you have first hand examples of administrative or procedural issues with the MRFF? Please contact us below.

The inception of the MRFF gave Australian researchers two sources of government funding for health and medical research – the National Health and Medical Research Council - NHMRC grants (which are expertly managed) and the MRFF.

As it turns out, a whopping 65% of these MRFF funds have been awarded without going through a competitive process. This may mean the best science isn’t being funded.

The Federal Government commissioned the McKeon report in 2011 in response to major backlash about funding cuts to the health and medical research sector. The review recommended an incremental increase to about 3% of total health expenditure over 10 years, totalling $2-3bn extra per year.

Guess how much the Australian Government currently funds health and medical research? A disappointing ~0.53%* of total health expenditure, a far cry from the recommendation to lift this investment to 3%.

It is clear that we need more funds than we have access to. At the very least, we also need the MRFF funds to go to the scientists that are doing the best research.

At the Australian Society for Medical Research, we are calling on the Australian National Audit Office (ANAO) to consider auditing the administration of the MRFF.

Speaking in Melbourne today, ASMR President, Associate Professor Christoph Hagemeyer said, “The ASMR has written to the ANAO strongly recommending that the planned audit of the MRFF is conducted and we are urging the sector to do the same. With sufficient public pressure, we are confident that the audit will go ahead and the transparency and governance mechanisms can be improved for the benefit of the health and medical research sector and the health of the nation”

The Australian Society for Medical Research President, A/Prof Christoph Hagemeyer is available for comment at [email protected]

Please find our full media release here:https://asmr.org.au/wp-content/uploads/2020/08/MRFF-Audit.pdf

12/05/2020

09/04/2020

https://asmr.org.au/wp-content/uploads/2020/04/Covid19.pdf

02/04/2020

hot off the press

As the complications of atherosclerosis such as myocardial infarction and stroke are still one of the leading causes of mortality worldwide, the development of new diagnostic tools for the early detection of plaque instability and thrombosis is urgently needed. Advanced molecular imaging probes base...

19/02/2020

https://www.hochschulverband.de/pressemitteilung.html?&no_cache=1&tx_ttnews%5Btt_news%5D=330&cHash=44869b6dc028c4a2277bec96f7281219

Die meisten Hochschullehrerinnen und Hochschullehrer an deutschen Universitäten fühlen sich in ihrer Forschung frei, doch es gibt auch eine ganze Reihe von Problemen, die die wissenschaftliche Arbeit behindern. Dies zeigen die Ergebnisse einer aktuellen Umfrage unter Universitätsprofessorinnen un...

06/02/2020

Our people and facilities are having an impact in the medicine world. It's inspiring and exciting. Find out how you can be part of something big.

17/01/2020

Global study highlights long hours, poor job security and mental-health struggles.

11/01/2020

First publication for 2020, a great collaboration with the University of Melbourne and RMIT.

The aerodynamic diameters of metal–phenolic capsules are nanoengineered by increasing their shell thickness, which facilitates tailored capsule deposition in a mechanical lung model. The engineered c...

06/12/2019

Central Clinical School, Monash University researches medicine, surgery, immunology, blood diseases, psychiatry & neuroscience.

11/10/2019

http://ccsmonash.blogspot.com/2019/10/monash-researchers-develop-new-gene.html

Central Clinical School, Monash University researches medicine, surgery, immunology, blood diseases, psychiatry & neuroscience.

04/10/2019

Nanomedicine is transitioning from a clutter of sample tables to a full-blown buffet. So, start grazing. Try this article’s diagnostic, drug delivery, and therapeutic offerings for a well-balanced read.